Table: OncoTherapy Science -2025/26 parent results

OncoTherapy Science

08/05/2026 09:00

May 8 (Reuters)- 
          OncoTherapy Science Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           2 mln           3 mln                                
               (-19.7 pct)    (+370.4 pct)                             
  Operating   loss 769 mln    loss 728 mln                             
  Recurring   loss 775 mln    loss 712 mln                             
  Net         loss 910 mln    loss 815 mln                             
  EPS         loss 2.77 yen   loss 3.12 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T